![]() |
|||||
|---|---|---|---|---|---|
| Winter 2025 Volume 18, Number 4 | |||||
This Just In ... Thanks to the continued rollout of the Inflation Reduction Act, Medicare Part D enrollees will see their annual out-of-pocket prescription drug costs capped at $2,100 starting January 1, 2026. This builds on the $2,000 cap introduced in 2025, offering continued relief for seniors managing high-cost medications. Before these reforms, beneficiaries faced unlimited drug costs once they entered the catastrophic coverage phase. Now, with a firm ceiling in place, you’ll have predictable protection—especially if you take medications for cancer, diabetes, heart disease, or autoimmune conditions. What This Means for You in 2026
Why This Matters Now Open Enrollment is your once-a-year opportunity to:
Agents are already helping clients evaluate their 2026 options. If you or a loved one are on Medicare, now’s the time to take stock and make sure your plan is aligned with your health and budget needs. [return to top]
|
|
This Just In ... Medicare Part D Out-of-Pocket Cap Increases to $2,100 in 2026 Medicare Drug Coverage Is Changing—Here’s What You Need to Know This Enrollment Season Aging Alone: Why Long-Term Care Planning Matters More Than Ever
Never Outlive Your Savings:
How Longevity Annuities Can Help
Traveling Abroad with Medicare: What You Need to Know
|
|||
|
|||||